Literature DB >> 16518767

Effects of cyclooxygenase-1 and -2 gene disruption on Helicobacter pylori-induced gastric inflammation.

Guo Qing Li1, Harry Hua-Xiang Xia, Min Hu Chen, Qing Gu, Ji De Wang, Jun Zhong Peng, Annie O O Chan, Chi Hin Cho, Hau Leung So, Shiu Kum Lam, Pin Jin Hu, Ying Jie Liang, Han Liang Lin, Douglas E Berg, Zhe Hui Feng, Robert Langenbach, Benjamin Chun-Yu Wong.   

Abstract

BACKGROUND: Cyclooxygenases (COXs) play important roles in inflammation and carcinogenesis. The present study aimed to determine the effects of COX-1 and COX-2 gene disruption on Helicobacter pylori-induced gastric inflammation.
METHODS: Wild-type (WT), COX-1 and COX-2 heterozygous (COX-1+/- and COX-2+/-), and homozygous COX-deficient (COX-1-/- and COX-2-/-) mice were inoculated with H. pylori strain TN2 and killed after 24 weeks of infection. Uninfected WT and COX-deficient mice were used as controls. Levels of gastric mucosal inflammation, epithelial cell proliferation and apoptosis, and cytokine expression were determined.
RESULTS: COX deficiency facilitated H. pylori-induced gastritis. In the presence of H. pylori infection, apoptosis was increased in both WT and COX-deficient mice, whereas cell proliferation was increased in WT and COX-1-deficient, but not in COX-2-deficient, mice. Tumor necrosis factor (TNF)-alpha and interleukin-10 mRNA expression was elevated in H. pylori-infected mice, but only TNF-alpha mRNA expression was further increased by COX deficiency. Prostaglandin E2 levels were increased in infected WT and COX-2-deficient mice but were at very low levels in infected COX-1-deficient mice. Leukotriene (LT) B4 and LTC4 levels were increased to a similar extent in infected WT and COX-deficient mice.
CONCLUSIONS: COX deficiency enhances H. pylori-induced gastritis, probably via TNF-alpha expression. COX-2, but not COX-1, deficiency suppresses H. pylori-induced cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16518767     DOI: 10.1086/500984

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Gastrokine 1 regulates NF-κB signaling pathway and cytokine expression in gastric cancers.

Authors:  Jung Hwan Yoon; Mi La Cho; Yoo Jin Choi; Ji Yeon Back; Mi Kyung Park; Suk Woo Lee; Byung Joon Choi; Hassan Ashktorab; Duane T Smoot; Suk Woo Nam; Jung Young Lee; Won Sang Park
Journal:  J Cell Biochem       Date:  2013-08       Impact factor: 4.429

2.  Expression of COX-2 in stomach carcinogenesis.

Authors:  Nora Manoukian Forones; Kharen Yaemi Kawamura; Helena Regina Comodo Segreto; Ricardo Artigiani Neto; Gustavo Rubino de Azevedo Focchi; Celina Tizuko Fujiyama Oshima
Journal:  J Gastrointest Cancer       Date:  2008-12-24

3.  Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.

Authors:  Chung-Wei Lee; Barry Rickman; Arlin B Rogers; Sureshkumar Muthupalani; Shigeo Takaishi; Peiying Yang; Timothy C Wang; James G Fox
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

4.  Dietary Supplementation With ω6 LC-PUFA-Rich Algae Modulates Zebrafish Immune Function and Improves Resistance to Streptococcal Infection.

Authors:  Sagar Nayak; Inna Khozin-Goldberg; Guy Cohen; Dina Zilberg
Journal:  Front Immunol       Date:  2018-09-06       Impact factor: 7.561

5.  Anti-Helicobacter pylori Properties of GutGard™.

Authors:  Jae Min Kim; Hong Mei Zheng; Boo Yong Lee; Woon Kyu Lee; Don Haeng Lee
Journal:  Prev Nutr Food Sci       Date:  2013-06

6.  In vitro and In vivo Anti-Helicobacter pylori Activities of Centella asiatica Leaf Extract.

Authors:  Hong-Mei Zheng; Myung-Joo Choi; Jae Min Kim; Kye Wan Lee; Yu Hwa Park; Don Haeng Lee
Journal:  Prev Nutr Food Sci       Date:  2016-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.